Pe­ter Kolchin­sky and Raj Shah raise a $300M fund de­vot­ed to biotech star­tups

Pe­ter Kolchin­sky and Raj Shah have an­oth­er $300 mil­lion-plus to play with on the biotech ven­ture side of their in­vest­ment busi­ness. 

The two an­nounced Mon­day morn­ing that they’ve put to­geth­er their first pure-play ven­ture fund at RA Cap­i­tal Man­age­ment, which has been known to bet on just about every an­gle in health­care in­vest­ing — from rounds to fol­low-on in­vest­ments at pub­lic com­pa­nies. This new fund of theirs ar­rives well in­to a go-go era of new start­up fi­nanc­ing, with a par­tic­u­lar fo­cus on build­ing new biotechs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER